Cardiac Rehabilitation for Stroke Survivors
Cardiac Rehabilitation of Stroke Survivors (SRP-CROSS)
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 150 (estimated)
- Sponsor
- Hackensack Meridian Health · Other
This trial is looking for patients who have had a stroke and want to participate in a cardiac rehabilitation program. It aims to see if this program helps with recovery, reduces hospital visits, and lowers the risk of having another stroke.
You may be able to join if
- I am 18 years or older.
- I have been diagnosed with a stroke.
- I have been cleared by my cardiologist to join a cardiac rehab program.
- I can safely use a recumbent bike with or without help.
- I can follow simple commands and communicate my needs.
- I am staying in an Inpatient Rehabilitation Facility after my stroke.
- I have signed the informed consent form.
You may not be able to join if
- I have a subarachnoid hemorrhage or an intracranial aneurysm.
- My doctor has said I can’t participate in this study.
- I cannot have the initial assessment within 60 days of my stroke.
- I am unable to comply with the study requirements.
- I have a terminal illness with a life expectancy of less than 1 year.
- I have a diagnosis eligible for cardiac rehabilitation covered by insurance.
- I cannot understand or speak English.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThis study examines the effectiveness of the cardiac rehabilitation program for stroke patients. The study will examine if patients with stroke, who receive cardiac rehabilitation in addition to their standard of care treatments, demonstrate improved recovery of function. It will also examine if these patients have reduced hospital readmission, reduced rate of recurrent stroke, and mortality.
Loading trial locations…